Interleukin-4 distinctively modifies responses of germinal centre-like and activated B-cell-like diffuse large B-cell lymphomas to immuno-chemotherapy.

Sarosiek, Kristopher A

Interleukin-4 distinctively modifies responses of germinal centre-like and activated B-cell-like diffuse large B-cell lymphomas to immuno-chemotherapy. [electronic resource] - British journal of haematology Nov 2009 - 308-18 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1365-2141

10.1111/j.1365-2141.2009.07851.x doi


Antibiotics, Antineoplastic--pharmacology
Antibodies, Monoclonal--pharmacology
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Apoptosis Regulatory Proteins--biosynthesis
Doxorubicin--pharmacology
Drug Evaluation, Preclinical--methods
Germinal Center--pathology
Humans
Interleukin-4--pharmacology
Lymphocyte Activation
Lymphoma, Large B-Cell, Diffuse--metabolism
Neoplasm Proteins--biosynthesis
Phosphatidylinositol 3-Kinases--physiology
Recombinant Proteins--pharmacology
Rituximab
Tumor Cells, Cultured